[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 5, 1967

WASHINGTON

JAMA. 1967;200(10):43-45. doi:10.1001/jama.1967.03120230029004

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Hearings On Drug Purchasing  Opening witnesses at Congressional hearings on drug prices contended that the government could save millions of dollars by purchasing drugs by their generic names.A Senate Small Business Subcommittee, headed by Sen. Gaylord Nelson (D, Wis), is holding the hearings in part to push bills that would make outpatient drug costs a Medicare benefit and that would encourage patients to ask their physicians and pharmacists to supply them cheaper generic equivalents.Noting that the first week's scheduled witnesses were all critical of the ethical drug industry, the Pharmaceutical Manufacturers Association urged in a statement that judgments be made only after all witnesses have been heard. PMA President C. Joseph Stetler said: "Our position is that the interests of the patient will best be served and the highest quality medical care be provided only if the physician remains unrestricted in his judgment of the medicine to

×